<DOC>
	<DOCNO>NCT00596752</DOCNO>
	<brief_summary>The study confirmatorily show superior effect Alprostadil compare placebo rate complete heal ischemic necroses ulceration well frequency height major amputation patient suffer PAOD stage IV .</brief_summary>
	<brief_title>Alprostadil Peripheral Arterial Occlusive Disease ( PAOD ) Stage IV</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Alprostadil</mesh_term>
	<criteria>Subject least 45 year age Subjects macroangiopathy , proven PAOD Stage IV 2 ischaemic skin lesion 2 week Subject complete angiography pelvis , thigh calf within one month inclusion Systolic ankle pressure ≤ 70 mmHg subject without medium sclerosis low limb artery systolic big toe pressure ≤ 50 mmHg diabetic medium sclerosis low limb artery Subject position primarily revascularized refuse surgery Imminent foreseeable amputation Major amputation affect extremity History chronic alcohol drug abuse More two ischemic ulceration One ulcer ≥ 6 cm^2 , ulcer ≤ 1 cm^2 least one ulcer affect bone tendon Acute ischemia peripheral vascular disorder inflammatory immunologic origin Neuropathic venous ulcer Buerger 's disease Septic gangrene Use vasoactive medication prostaglandin Treatment prostanoids within 3 month prior inclusion Surgical interventional measure perform affected extremity within 3 month prior study drug treatment</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Alprostadil</keyword>
	<keyword>Prostavasin</keyword>
	<keyword>PAOD</keyword>
	<keyword>Fontaine Stage IV</keyword>
</DOC>